Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_assertion type Assertion NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_head.
- NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_assertion description "[We utilized upstream regulatory sequences from either the human alpha-lactalbumin (hALA) gene, or the ovine beta-lactoglobulin (oBLG) gene in these vector constructs to target expression of heterologous genes transcriptionally to breast cancer cells both in vitro and in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_provenance.
- NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_assertion evidence source_evidence_literature NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_provenance.
- NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_assertion SIO_000772 10505111 NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_provenance.
- NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_assertion wasDerivedFrom befree-2016 NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_provenance.
- NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_assertion wasGeneratedBy ECO_0000203 NP264452.RAVb8dFQbe585s7b1h0MrgMN0qBnx2OTcV2_UCn7BQp_I130_provenance.